377 related articles for article (PubMed ID: 7862446)
1. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
[TBL] [Abstract][Full Text] [Related]
2. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters.
Rutberg SE; Saez E; Lo S; Jang SI; Markova N; Spiegelman BM; Yuspa SH
Oncogene; 1997 Sep; 15(11):1337-46. PubMed ID: 9315102
[TBL] [Abstract][Full Text] [Related]
3. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
4. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1.
Murakami M; Sonobe MH; Ui M; Kabuyama Y; Watanabe H; Wada T; Handa H; Iba H
Oncogene; 1997 May; 14(20):2435-44. PubMed ID: 9188858
[TBL] [Abstract][Full Text] [Related]
6. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.
Hadman M; Loo M; Bos TJ
Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933
[TBL] [Abstract][Full Text] [Related]
7. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
8. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
9. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
10. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
Catling AD; Wyke JA; Frame MC
Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
[TBL] [Abstract][Full Text] [Related]
11. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
12. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
Tay DL; Hoffbrand AV; Wickremasinghe GR
Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1.
Ito E; Sweterlitsch LA; Tran PB; Rauscher FJ; Narayanan R
Oncogene; 1990 Dec; 5(12):1755-60. PubMed ID: 2178237
[TBL] [Abstract][Full Text] [Related]
15. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
16. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
Beiqing L; Chen M; Whisler RL
J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
[TBL] [Abstract][Full Text] [Related]
17. Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements.
Adiseshaiah P; Peddakama S; Zhang Q; Kalvakolanu DV; Reddy SP
Oncogene; 2005 Jun; 24(26):4193-205. PubMed ID: 15806162
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development.
Carrasco D; Bravo R
Oncogene; 1995 Mar; 10(6):1069-79. PubMed ID: 7700631
[TBL] [Abstract][Full Text] [Related]
19. Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 DNA binding activity in the mammalian brain.
Sonnenberg JL; Mitchelmore C; Macgregor-Leon PF; Hempstead J; Morgan JI; Curran T
J Neurosci Res; 1989 Sep; 24(1):72-80. PubMed ID: 2553994
[TBL] [Abstract][Full Text] [Related]
20. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK.
Murakami M; Ui M; Iba H
Cell Growth Differ; 1999 May; 10(5):333-42. PubMed ID: 10359014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
